Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Infection Prevention”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Early research (Phase 1)UnknownNCT02958540
What this trial is testing

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

Who this might be right for
Respiratory Syncytial Viral Infections
Mucosis BV 48
Early research (Phase 1)Study completedNCT03473002
What this trial is testing

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Who this might be right for
Antiviral ProphylaxisRespiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 21
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Large-scale testing (Phase 3)Study completedNCT05101486
What this trial is testing

An Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 755
Large-scale testing (Phase 3)Study completedNCT06083623
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 2,282
Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Vicebio Australia Proprietary Limited 144
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Large-scale testing (Phase 3)Ended earlyNCT04605159
What this trial is testing

A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 11,194
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Not applicableStudy completedNCT01545245
What this trial is testing

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Who this might be right for
Atopic AsthmaRecurrent Wheezing
Tokai University 343
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Early research (Phase 1)Study completedNCT00192504
What this trial is testing

Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Prophylaxis
MedImmune LLC 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT07208461
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Guangzhou Patronus Biotech Co., Ltd. 700
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Not applicableStudy completedNCT00384462
What this trial is testing

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 346
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Load More Results